Latest News and Press Releases
Want to stay updated on the latest news?
-
Kensana Health secures $120M from GEM to advance AI-driven plant-based medicines, with lead drug KV23a and plans for NASDAQ listing in Q2 2026.
Want to stay updated on the latest news?
Kensana Health secures $120M from GEM to advance AI-driven plant-based medicines, with lead drug KV23a and plans for NASDAQ listing in Q2 2026.